Literature DB >> 8575078

Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury.

J S Lee1, C Adrie, H J Jacob, J D Roberts, W M Zapol, K D Bloch.   

Abstract

Systemic and local intravascular NO administration inhibits neointimal formation after vascular injury in animal models. NO appears to attenuate smooth muscle proliferation both directly and indirectly by preventing the release of growth factors. Inhalation of low concentrations of NO dilates pulmonary vascular smooth muscle but does not cause systemic vasodilatation. Recently, NO inhalation was found to inhibit platelet function in vivo. We studied the effects of NO inhalation on neointimal formation after balloon-induced injury of the adult rat carotid artery. Beginning 60 minutes before carotid injury, rats breathed either air with 0 or 80 ppm NO for 14 days. Rats were killed, carotid arteries were fixed and paraffin-embedded, and neointimal formation was measured by analyzing the ratio of intimal to medial areas (I/M ratio) in carotid artery cross sections. Intimal hyperplasia was evident in both groups of animals, but I/M ratios were 43% less in animals breathing 80 ppm NO for 2 weeks than in animals breathing air alone (0.78 +/- 0.12 and 1.37 +/- 0.11 [mean +/- SE], respectively; P < .02). Similarly, 1 week after carotid injury, neointimal formation was less in rats breathing 80 ppm NO than in rats breathing air alone (I/M ratio, 0.39 +/- 0.11 versus 0.76 +/- 0.06; P < .02). Breathing 20 ppm NO for 2 weeks or 80 ppm NO for 1 week followed by air alone for 1 week did not attenuate neointimal formation measured at 14 days. In anesthetized rats breathing 80 ppm NO or air alone for 1 hour, neither systemic blood pressure nor bleeding time differed. These observations demonstrate that inhaling 80 ppm NO inhibits neointimal formation after balloon-induced carotid artery injury in rats. NO inhalation may represent a safe and novel method of preventing restenosis after percutaneous angioplasty.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8575078     DOI: 10.1161/01.res.78.2.337

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  26 in total

Review 1.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

2.  Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.

Authors:  L L Shears; N Kawaharada; E Tzeng; T R Billiar; S C Watkins; I Kovesdi; A Lizonova; S M Pham
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Plasma detection of NO by a catheter.

Authors:  Masami Goto; Seiichi Mochizuki
Journal:  Med Biol Eng Comput       Date:  2008-05       Impact factor: 2.602

4.  Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.

Authors:  Claudio Napoli; Giancarlo Aldini; John L Wallace; Filomena de Nigris; Roberto Maffei; Pasquale Abete; Domenico Bonaduce; Gianluigi Condorelli; Franco Rengo; Vincenzo Sica; Francesco P D'Armiento; Chiara Mignogna; Gaetano de Rosa; Mario Condorelli; Lilach O Lerman; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

5.  Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia.

Authors:  Shao-Ling Huang; Patrick H Kee; Hyunggun Kim; Melanie R Moody; Stephen M Chrzanowski; Robert C Macdonald; David D McPherson
Journal:  J Am Coll Cardiol       Date:  2009-08-11       Impact factor: 24.094

6.  Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds.

Authors:  A Fox-Robichaud; D Payne; S U Hasan; L Ostrovsky; T Fairhead; P Reinhardt; P Kubes
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

7.  Attenuated inhibition of adrenergic contraction by nitric oxide in injured guinea pig femoral artery.

Authors:  H Matsuda; A Kawaguchi; J Tamai; M Uematsu; S Nagata; K Miyatake
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

8.  Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.

Authors:  Zachary W Q Moore; David Y Hui
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

Review 9.  Progress in understanding the pathogenesis of BPD using the baboon and sheep models.

Authors:  Kurt H Albertine
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

10.  Brief periods of nitric oxide inhalation protect against myocardial ischemia-reperfusion injury.

Authors:  Yasuko Nagasaka; Bernadette O Fernandez; Maria F Garcia-Saura; Bodil Petersen; Fumito Ichinose; Kenneth D Bloch; Martin Feelisch; Warren M Zapol
Journal:  Anesthesiology       Date:  2008-10       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.